Stem Cell is selling for 0.0146 as of the 11th of December 2024. This is a No Change since the beginning of the trading day. The stock's lowest day price was 0.0146. Stem Cell has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat ok performance during the last 90 days. The performance scores are derived for the period starting the 11th of November 2024 and ending today, the 11th of December 2024. Click here to learn more.
Stem Cell Authority, Ltd., a technology development company, focuses on the collection and cryogenic preservation of stem cells. The companys technology enables birthing professionals with a stem cell preservation program to serve their maternity patients in the United States. The company has 348.71 M outstanding shares. More on Stem Cell Authority
Stem Cell Authority [SCAL] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Nano-Cap' category with a current market capitalization of 2.34 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Stem Cell's market, we take the total number of its shares issued and multiply it by Stem Cell's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Stem Cell Authority conducts business under Healthcare sector and is part of Medical Care Facilities industry. The entity has 348.71 M outstanding shares.
Check Stem Cell Probability Of Bankruptcy
Our tools can tell you how much better you can do entering a position in Stem Cell without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run Pair Correlation Now
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Stem Cell financial ratios help investors to determine whether Stem Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Stem with respect to the benefits of owning Stem Cell security.